BIOMARIN PHARMACEUTICAL INC (BMRN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2008: $39.76M2009: $16.43M2010: $544.0K2011: -$33.89M2012: -$110.22M2013: -$156.01M2014: -$92.89M2015: -$110.70M2016: -$803.43M2017: -$14.70M2018: -$123.52M2019: -$100.46M2020: -$43.44M2021: -$82.34M2022: $160.97M2023: $185.77M2024: $484.21M2025: $409.48M$409.48M
2008Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$409.48M-15.4%
2024$484.21M+160.6%
2023$185.77M+15.4%
2022$160.97M+295.5%
2021-$82.34M-89.6%
2020-$43.44M+56.8%
2019-$100.46M+18.7%
2018-$123.52M-740.3%
2017-$14.70M+98.2%
2016-$803.43M-625.8%
2015-$110.70M-19.2%
2014-$92.89M+40.5%
2013-$156.01M-41.5%
2012-$110.22M-225.2%
2011-$33.89M-6329.8%
2010$544.0K-96.7%
2009$16.43M-58.7%
2008$39.76M